One of the most common diseases affecting the central nervous system is multiple sclerosis. Up till now interferon-beta was found out to be effective in reducing the progress of the disease and the relapse rate. Fraunhofer laboratory’s therapeutic protein has become the first protein to get the approval as a biogeneric medicine.
Human protein was successfully cloned into a suitable expression vector which led to the production of natural protein by stable transfection in a mammalian cell line. Developed as a pilot, under it the company developed both the fermentation as well as the downstream processing which led to the creation of a highly purified protein. The protein was identified by sequencing of amino acid and this led to antiviral effects
Via uni-protokolle
